Functional characterization of novel bumetanide derivatives for epilepsy treatment
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 162, 107754
Abstract
No abstract availableKeywords
Funding Information
- Austrian Science Fund (W1206-B05, P30430-BBL, P30592-BBL)
This publication has 51 references indexed in Scilit:
- Patterns of treatment response in newly diagnosed epilepsyNeurology, 2012
- Molecular mechanism of circadian rhythmicity of seizures in temporal lobe epilepsyFrontiers in Cellular Neuroscience, 2012
- Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbitalBrain, 2011
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesEpilepsia, 2008
- Prodrug Approaches for CNS DeliveryThe AAPS Journal, 2008
- Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptorsBrain, 2007
- Interactions of Human Organic Anion Transporters with DiureticsThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Diuretics as Antiepileptic DrugsEpilepsy Currents, 2002
- Structure-Activity Relationships of Aminobenzoic Acid Diuretics and Related Compounds (1)1978
- Aminobenzoic acid diuretics. 7. 3-Substituted 4-phenyl-, 4-arylcarbonyl-, and 4-arylmethyl-5-sulfamoylbenzoic acids and related compoundsJournal of Medicinal Chemistry, 1975